Monthly Archives: October 2016


KMR’s rich data sources and experience, and comprehensive tools can benefit your company’s development. In many areas, in many ways


  • Enrollment Metrix
  • Enrollment Forecasting
  • Country Optimizer
  • Study Startup Evaluation
Enhance study startup and optimize enrollment performance. Invaluable for clinical trial strategy and planning, country selection, forecasting, startup, and feasibility.


  • NextGEN Site Scorecard
  • Site Metrix
  • Site Contracts
  • Site Optimization
  • Site Performance Study
  • Site Benchmarks for Sites
Applications and reports for site planning, site selection, and improving performance and timelines.
Used to select top performing sites. Used to engage with sites.


  • CRO Metrix Application
  • CRO Rankings Report
  • Outsourcing Performance Assessment
Resources to help understand outsourced study expectations and performance improvement


  • Trial Cost Metrix Application
  • Trial Cost Study
  • Trial Cost Predictive Models
  • Project Cost Application
  • Project Cost Study
Understand the cost of clinical trials or projects by myriad components. Access current cost benchmarks and inform your clinical trial and portfolio cost strategies.

Cycle Time

  • Cycle Time Metrix
  • Cycle Time Study
  • COVID Supplement
  • Clinical Performance Scorecard
  • Phase IV/Medical Affairs Study
KMR Group’s Cycle Time program offers a comprehensive solution to both evaluate cycle time performance and to make available data for use in day-to-day decision making

Trial Cost Metrix

Provides access to an unparalleled pool of cross-industry comprehensive trial cost data that covers personnel, outsourcing, grants and more

Trial Cost Study

The Clinical Trial Cost Study offers a comprehensive assessment of trial cost performance including whether your company runs high cost studies; whether it tends to run studies that are more expensive than its peers when normalized by disease; and whether it is cost efficient in terms of executing its trials. The Trial Cost Study sets the standard in terms of clinical trial cost benchmarks enabling evaluation at a variety of levels including resource, grants and more

CRO Metrix

Process metrics to assess outsourcing performance such as site selection/startup. Compare sponsor vs. CRO conducted studies and generate custom scorecards for your CROs

Project Cost

A key component of any R&D Productivity measure is generally associated with cost. As such, it is fundamental to understand how much it costs to pursue any given drug development project whether it be internally, with a co-development partner or as part of a licensing or acquisition deal. KMR Group has worked with companies to devise a reliable, robust, and systemic way to extract the cost incurred for each project in your portfolio using a top-down approach making the final figures appropriate and comparable for benchmarking, forecasting, and planning or to calculate the full cost of drug development